Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons
- 1 November 2000
- journal article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 61 (1) , 69-84
- https://doi.org/10.1016/s0376-8716(00)00122-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboonsDrug and Alcohol Dependence, 2000
- Zaleplon displays a selectivity to recombinant GABAA receptors different from zolipdem, zopiclone and benzodiazepinesNeuroscience Research Communications, 1999
- A Review of the Preclinical Development of Zaleplon, a Novel Non‐Benzodiazepine Hypnotic for the Treatment of InsomniaCNS Drug Reviews, 1997
- Pharmacokinetics and Pharmacodynamics of Triazolam After Two Intermittent Doses in Obese and Normal-Weight MenJournal of Clinical Psychopharmacology, 1995
- Benzodiazepines, appetite, and taste palatabilityNeuroscience & Biobehavioral Reviews, 1995
- A Placebo‐Controlled Evaluation of Single, Escalating Doses of CL 284,846, a Non‐Benzodiazepine HypnoticThe Journal of Clinical Pharmacology, 1994
- Oral self-administration of triazolam, diazepam and ethanol in the baboon: drug reinforcement and benzodiazepine physical dependencePsychopharmacology, 1992
- Periodic benzodiazepine antagonist administration prevents benzodiazepine withdrawal symptoms in primatesEuropean Journal of Pharmacology, 1986
- Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepinesCellular and Molecular Life Sciences, 1982
- A sensitive open field measure of anxiolytic drug activityPharmacology Biochemistry and Behavior, 1981